ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001224.1|Reductasporine_1 # 1 # 1035 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.684	BGC0001224.1|Reductasporine_1 	1	1035	+	Loose	550	26.5646	RlmA(II)	38.71	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGAGTGACACGTCTCCCGGCCCGGAACACGCCCCGGCAATCGATCGTCTGCTGCAGATCGCCACTGGTTTCATGGCGTCGAAGGTCCTCCTCGTCGCCGCCAGCCTCGGCCTCTTCACCGAACTCGCCGCAGGCCCGTTGCGCGGCGAGGAGCTGCGCGCCCGGCTAAGGCTGCACCCCCGTTCCGCCCGTGACTTCTTCGACACCCTCGTCGCTCTCGGCGTCCTGGAGCGCACCAACGGCGCGTACGCGAACACTCCCGCCACCGCCCAGTACCTCGTCCGCGGCAAGTCTGCCTACCTGGGCGGTCTCCTGGAGATGAGCGACGCCAGGATGTACGAGCTCTGGGGGAGGCTCGACGAGGGCCTGCGGACCGGAAACCCGCAGAACGAGATCAGGACCGGCGAGGAGGGCATTTACGCGACCCTGTACGACGACCCCGACCGCCTCGACGCCTTCCAGCAGGCCATGACCGGCCTGTCCATGCGCTCCGCACATGCCCTGGCCGAGGCGATCGACTGGTCTGCCTACCGCACCGTCGCGGATATCGGCTGCGCCGAGGGCACCGTGCTGATACACCTGCTCGAGCGCCATCCCCATCTGCGCGGCACTGGCTTCGACCTGGCCGCCGTCCGTCCCAGCTTCCAGCGCCGCCACGAGGAGTCCGGTCTCGGTGACCGGCTCGCGTTCCGCGCCGGCGACTTCTTCGCCGAGCCGCTACCGCAGGCCGACGCGCTGGTTTTCGGGCACATCCTGAGCAACTGGGCCCTGCCCAAGGCGAAGACGCTGCTGCGCAAGGCTCACGAGGCGCTGCCGGAGGGCGGCATCGTGGTCATCTACGAGACCCTCATCGATGATGAGCGCCGGGAGAACGTTCCCGGACTGCTCATGAGCCTCACCATGCTCCTGGAGACCCCCGGTGGCTTCGAGTACACGGGCGCGGACTGCCGCGAGTGGCTGGCGGACGCCGGGTTCCGTGAGAGCCGGGTGCAGTACCTGGCAGGGCCGGAGTCAATGGTGATCGCCACCAAGTGA	MSDTSPGPEHAPAIDRLLQIATGFMASKVLLVAASLGLFTELAAGPLRGEELRARLRLHPRSARDFFDTLVALGVLERTNGAYANTPATAQYLVRGKSAYLGGLLEMSDARMYELWGRLDEGLRTGNPQNEIRTGEEGIYATLYDDPDRLDAFQQAMTGLSMRSAHALAEAIDWSAYRTVADIGCAEGTVLIHLLERHPHLRGTGFDLAAVRPSFQRRHEESGLGDRLAFRAGDFFAEPLPQADALVFGHILSNWALPKAKTLLRKAHEALPEGGIVVIYETLIDDERRENVPGLLMSLTMLLETPGGFEYTGADCREWLADAGFRESRVQYLAGPESMVIATK	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	121.99	gnl|BL_ORD_ID|2052|hsp_num:0	2274			291	384	tylosin; mycinamicin
BGC0001224.1|Reductasporine_2 # 1210 # 2097 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.686	BGC0001224.1|Reductasporine_2 	1210	2097	-	Loose	500	28.8758	PER-12	28.79	3006133	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam; penem	antibiotic inactivation	PER beta-lactamase	ATGGGTGCCAAGGTGACAGTCCTGGGTCTCGGGCCGATGGGCGCCGCGCTGGCAGGCGCGTTCCTGGCGGCCGGCCACCGGACGACCGTCTGGAACCGCACGCCCGGGAAGGGTGGCTCCCTGGCCGGAGAGGGTGCCACAGAGGTGGCGTCGGCCGCCGAGGCCGTCGCCGCCAGCCCGCTGGTCGTGGTCTGTCTGGCGACGTACGAAGCCGTCCACGAGGTCCTTGACCCTCTGGCCGACGAACTTGCCGGCCGTACGGTCGTCAACCTCACCTCGGGCTCGCCGGTGCACGCACGCGAGACGGCCAACTGGGCGCAGCAGCACGGCGCCGAGTACCTCGACGGCGTGATCATGACTACTCCCTCCGGCATCGGCAAGCCGGACTACCTGCTGCTCTACAGCGGCTCGCAAGCCGCCTTCGACGGCAGCCGCGGGACGCTCTGCGCCCTGGGCGAACCGATGAACCTGGGCACCGATGCCGCGATGGCCTCCGTGTACGACACCGCGCTGCTGGGGCTGATGTGGGGCACGCTGACCGGCTGGCTGCACGGAGTGGCACTCATGGGCGCCGACGGGCCCGGCGGCAACGTAACGGCGACGGCATTCACGGAAGTGGCCAACCGGTGGATGAAGACGGTCGGCGTCTTCATGAATACCTACGCCCCACATGTGGACGCTGGGCACTACCCGGGTGACGAGTTCACTCTTCACCTGCACCACAGGACGATGAACATCCTTGCCCACGCGAGCGAACTGCGTGGGGTGGTGTCCGGCCTCCCGGAACTTCTCACGGAACTGACCGGGCGGGCGATCACGGCCGGACACGGCAACGACAGCTACGCACGCCTGGTCGAGTTCATCCGCAAGGACGGCAGCCCCATCTGA	MGAKVTVLGLGPMGAALAGAFLAAGHRTTVWNRTPGKGGSLAGEGATEVASAAEAVAASPLVVVCLATYEAVHEVLDPLADELAGRTVVNLTSGSPVHARETANWAQQHGAEYLDGVIMTTPSGIGKPDYLLLYSGSQAAFDGSRGTLCALGEPMNLGTDAAMASVYDTALLGLMWGTLTGWLHGVALMGADGPGGNVTATAFTEVANRWMKTVGVFMNTYAPHVDAGHYPGDEFTLHLHHRTMNILAHASELRGVVSGLPELLTELTGRAITAGHGNDSYARLVEFIRKDGSPI	MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWSPMMEEHPGDEFTVAVQQLLQYSVSHSDNVACDLLFELVGGPAALDAYIRSIGVKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGVRAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQAAYQFELKKLSALSPN	95.78	gnl|BL_ORD_ID|4545|hsp_num:0	5615			282	444	
BGC0001224.1|Reductasporine_3 # 2471 # 3913 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.723	BGC0001224.1|Reductasporine_3 	2471	3913	+	Loose	750	28.4906	tet(50)	19.17	3004584	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGGCAGGCCTCGTCGCGGCGCACGAGCTGGAGCGGAACGGCCACCGGGTCGAGGTGCTCGAGGGCGGCACACGCATCGGCGGCCGTGTGTACACGCACCGCTTCGGCACCGGACCGGATGGGCCGAGTGCGGAACTGGGCGCCATGCGCATCCCCGCCGACCACCGGCTCACGCTGGAGTACGTCAGGTTACTGGGGCTCGAGGGGGATCTCCGCCCCTTCACGACACTGCTGTCGGAGCAGAACGCGTATCTGCGGACCGCCGCCGGACTCGTGCGGATCCGCGACGCGGCCCGGCCGCTGTGCGAGAGCTTCCGGCGCGAGCTGGAAATTCACCGGCCCGGGCTGTGCCCCAGCCACGAGGTCATGGTCTTCGCCGCGTGGCTGACGGCCATCATCGACGCCATCGCCCCGCCCGACCTGCGCGAGGCGCTCCGCGAGGATCTGCGCGGCCAGCTCCTCGACCTTGTCGCGTGCGTCGATCTGATGCCGCACCTGCGCGGCGCGGCCGGGGACCGGGTCAGTCTGCATTCGCTTTTCTCCGCGCACCCGGGCCTGCGCGTGGGGCTCAGCCCACGGCTCAACAGCTTCCTGGACGACATCCTCGCCGAGACCAGCCCGGCGCTGCTGCGGCTTCACGGCGGCATGGACCGGCTCCCGCGCAGGCTGGCGGAACGGCTCGCGGGCCCGGTGCACCGCGGTCACTTGATCGTGGGCATCCAGGTGCGGCAGCACGACGTCCGGGTCTGGGTGCGCGCGAAGAACCGGACGACGGTGCGCCACGCCGATTTCGCCGTCTGTGCTCTGCCCTTTCCTTCGCTGTTGCGGATACGTCTGAGCGGACTGGACGCCGACAAGTTGGCGGTGCTGGGCGACGTGGAATACTGCCCGGCCACCAAGGTGGCCTTTCACTGCCGTGAGCCGTTCTGGCAGGCGTACGGCATCCAGGGAGGGGCCTCGTCCACCGGCGGGCGGATACGCCAGACCTACTATCCGCCCGTCGACGGCGCCCCGGAGCGCGGGGCCACGCTGCTGGCCAGCTACACGATCGGGGCGGAGGCCACCCGCCTCGGCCGGCTGCCGAGGCGCCGCAGGCACCGCCTCGTCCTGGCCGAACTCAGCGCGGTCCACCCCGAACTGCTGCGGCCCGGCATGGTGCTGGGCGCCGTGAGCATGGCCTGGGGGAACGGCGCGCCGTGGAGCGTCGGGTGCGCCACACGCTGGGGCAAAAGCCCCGACCAGTGCGAGACCGAACGCGCCCGTGCGGCCCGGCCGGTGAGGAACCGTCTGTTCTTCGCGGGCGAGCACTGCTCAGCGGCCCCCGCGTGGATCGAGGGTGCGATCGCATCGGCCCTGCAGGCCGCTGAGGATCTCACCCGCTTCGGGCCGGACCGCCGGCCCCGGACCGCCTCCGACCGCCACGACACCGCGGGAGCCCCGTGA	MAGLVAAHELERNGHRVEVLEGGTRIGGRVYTHRFGTGPDGPSAELGAMRIPADHRLTLEYVRLLGLEGDLRPFTTLLSEQNAYLRTAAGLVRIRDAARPLCESFRRELEIHRPGLCPSHEVMVFAAWLTAIIDAIAPPDLREALREDLRGQLLDLVACVDLMPHLRGAAGDRVSLHSLFSAHPGLRVGLSPRLNSFLDDILAETSPALLRLHGGMDRLPRRLAERLAGPVHRGHLIVGIQVRQHDVRVWVRAKNRTTVRHADFAVCALPFPSLLRIRLSGLDADKLAVLGDVEYCPATKVAFHCREPFWQAYGIQGGASSTGGRIRQTYYPPVDGAPERGATLLASYTIGAEATRLGRLPRRRRHRLVLAELSAVHPELLRPGMVLGAVSMAWGNGAPWSVGCATRWGKSPDQCETERARAARPVRNRLFFAGEHCSAAPAWIEGAIASALQAAEDLTRFGPDRRPRTASDRHDTAGAP	MTKHIKILVIGVGVAGPAVAYWLKRFGFSPVLIEKSAAVRKGGQALDIRGIATHIAKEMGIYDQICNMRTQIKCGRYVDVKGNVLHEEQGETFGFRQDDEVEILRGDLVEILMKAIADIPCEFKQSVIKIEQNEDSVTVTYKDGRVENYDLVIAADGIHSATRGMVFSKNEYQLINLGSYVSAFTIPNYLGLDHMELLCESNHKLVTLQSDSQADKAMAGFMFRSKHVLEDIRDEQEQKHFLHASFQNFGWETQNILNRMPESDDFYFDAITQIKMKSWTKGRIALIGDAAYCPSPLSGQGNNLAFVGAYILAGELKKADGDYIQAFTRYNELLHPFVEANQQFGVWVSESFLLKDDEVSKEIAEARSNKILAMIKSVSNSINLPQYE	123.71	gnl|BL_ORD_ID|2722|hsp_num:0	3287			801	1155	tetracycline; oxytetracycline
BGC0001224.1|Reductasporine_4 # 3913 # 7188 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.709	BGC0001224.1|Reductasporine_4 	3913	7188	+	Loose	900	29.6462	MdtK	27.45	3001327	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGAGCGTATTCGACCTGCCGCGGCTGCACTTCGCCGGAACTGCGACGACCGGGCTGCCGACCGGCCCGCGCTGCGGGCTGATCGACCTCGCCGCCAACCGGGCGCTGACCGACGACGGCCCCTTGTCCAGGGACCGGCCCGCTGCCGAGTACCACGACTTCCTGCACCGGCGCGGACCGCGCTTCGGCCGCGACGGACAGCCCGAGGCAGAAGGGGAGTTCAGCACCGCCACAGGCTCGAACTTCAACGGCAACGGGCACTTCCGGCTGGACACCCGCATCATCTGCGCAGAGCTGCCGGACGGTCAGACCGGTCACGGCGGCGCCCCCACCGATCCGGTGATCGGCAGCAGTGTCGACGTCTGGGGTCACTACAACCCGTACCTGCGCACCACCGTCAACCGCGCGCGGGTCCTCGACCTCGACCCGGCCTCCCGTTGGACGGCGGCGCTGATGGTCGGGCGGTTCGGCCTTGGCCGGCGCGGCCGCTCGCACGACGACGGCTACCTCTTCACCGGCGCAGTCAGCGGCCTCCATCCGCCACGGTGGGTCGACTTCCACCACATCCGCGATGTCGGAGACCATGTTCTGGCCCCGCAGCTGCGCTACTGCGCGGTCCACCAGTTCGTGGTGGAGCGAGGCTCCCTCGACTGGTTGCCGGAGGCGGACCGGTCCCCCGCCGTGAGCGCCCTGCACGCCGCGCTGCAGGCCGGAGCGGACGGCATCCTGGTGCAGCTCGCTCTGGACGCTATGGCTTCGCCACAGGTTCCCGACGCGCCCAGCCAGTGGCGGGTCCGGGGAACGGTCGCCCCCTGGAACGCCCAAGAACTGCGCACCTACCCGGCCGGGCGGTTGCTCGTCCCACTCCGAGGTGCCCCGCTGCACCACCTCACCGTGGAAGTGTCGCGCGGACGCGCCGTGTTCAACATGGTCTCCGCCGTGGCTTACGCCTCCCGGGCACCGCAGCCGGGTCCGGGGCCGCTGCACCGGCTCGGGCCACCGCTGGACGCCGGTGAGCTGGAGCTGCGTACGGCCGGTCATGACCGTCTGGTCGCCAGGGTGCCGCCGAACGCGTACCCCGCCGACGCGACGTGCGGGATCGTCACCGTGCCCGCCGAGCCCGGCTGGCAGGAGGCCGAGGAGCACGCGCTGTACCTGACCGGCGTCGGGGCCTCGGGCAGCCGGGAGACGCTGCTCACCGAGCGGGAGACCAACATCCAGACGGATGAGGCGCTGCTGGTTCTGCATCACCGCGACCCGACGCACGGGCGTGATCACGCCGTGGAGGTGCCGCTGCGTGCCTACGTGCGCGGCCGGCCTGCCAGCGCCGGGAAGGTGTATGTACGGCAGTACTTCAACCCCCGTGCCCTGCCCGGCGACAGCACGGCGGGTGCGCCCGCGGCGCGCTGCGGTGACGCGGTGATGCTCGGTATGCGCGGGGAGACGTGGGCCCCCGAATGCGTGGTGGAGACCGACGAGCAGGGGCACGGGCTCCTCACTCTGCGCGGTGAGCGCGCGGGTACCTGCCGCGTCCTGCTCTGCCCCGACCCGGCCGACGTACCTCCCGCCGATCCGCGCGCGCCGGGCTCGGCCTGGAAGGTGTACGACGACGAGGATGCGCTCGGCTACTGGGCGGGGGCCGCCTCTCTCGCCGTGCGGGTCCTGCCCGATGACTGGTATCTGGACGATGTGCCGCGCGGCGAGGTCGACTTCGAACTCGTGCACCGGGAGGTCTTCGCCTACTACGAGCACATCTCCTCCTTCATGCGCTCCGAGGTCTTCAGCCTTGCCGACCGCTGCAAGGTGGAGACCTACGCCGAGCTGGTCTGGCAGATGTGCGATCCGGCGAACAAGTCGAAGACGTACTACATGCCGCCGACCCGCGATCTGTCCGACCCCAAGGCCCGGCTGCTGCTGGCGTACCTGCGCAACATCCAAACGCGCGTCCGGCCACCGGTGACCGCACCGGGCCCGCCGGCGGAGCGGCCTGCGATCACCACGCGGGGCGAGCTGTGGACCGCGCTGAAGCAGGCGGCCGCGTTGGAGCTCTCGGTGGCGCTCCAGTACCTGTACGCGGCCTTCTCCGTACCGACCCACGGGGCAGGGCTCACGTACGTGCGCCGGGGCCAGTGGACGGCGGCGCAGCTGGAACTGGCCTGCGGCGGGGGAGGGGCGACGCTGCATGACGGGATGCGTGGCAGCCTGCTGACCGTGGCCCGCGAGGAGATGATCCACTTCTTGCTGGTGAACAACATCATCATGGCGATGGGGGAGCCGTTCCACGTCCCGGTGATCGACTTCGCCACGCTCAACGAGAAGCTGCCGGTCCCGCTGGACTTCGCCCTGGAGCCGCTGAGTGTCGGCAGCGTGCAGCGTTACGTCGCCCTTGAGCAGCCGGCGGCACTCACCCCGGAGATCCGGCGGGGCCCCCGTACCACCCCCCAGGAAAGGGCAGCGGGCTTCACCTGGGGATCGGTCAGCGAACTGTACGCGGGGGTGCGCGAAGGGCTGCAGCGCGTCCCGGACCTGTTTCTGGTGGAGAAGGGGCGCGGCGGCGGTGAACACCATCTTTTCCTGCGGGAGTCGGTCAACAGGAACCATCCGGACTATCAGCTGGAGGTCGACGACCTCTCGAGCGCCCTGTTCGCCGTCGACCTCATCACCGAGCAGGGCGAGGGCGGTCCGGCCACAGCCGGAGGGCCGGCTGCCGACGCCTCCTCGGAGATGTCGCATTTCGAGACGTTCCTGCGGATCGGCGAGCTGCTGGCCACCGGGCGAGCGCCCGGCCCGTACGGGCGGCACGTGCCATGGAGCCCCGCCTACCCGGTGCTGCGCAACCCGACGCTGAAGGCGGGCGACGGGGCGAGGACCGTCATCACCGACCCCGAGGCCCGGACCGTAGCGGCGCTGTTCAACCGCTCGTACCACTTGATGCTCCAGCTGATGGCACAGCATTTCGGCGAAAGCCCGGACGCCAGCCTGCGGCGCTCGAAGCTCATGAACGCCTCCATCGACGTGATGACCGGCATGATGCGCCCGCTCGCGGAGCTGCTCGTCACCATGGACTCGGGGCGGCGCGGCAGAACAGCGGGGCCGACGTTCGAGCTGGACGTGGTGCCCGCCGCCTGCCCGCGCCCCGATGTGGCGCGCCGCTCCCTCGCACTGCGTTTCGCGCATCTCGCGACGGCGGCACGCAGGTGCGCTCCCGTGCCCCGACAGGTCAGCGACCTCATGGCGTTCTACGCCGACTTCTTCCAGCGCGCGGAAGGTACGTGA	MSVFDLPRLHFAGTATTGLPTGPRCGLIDLAANRALTDDGPLSRDRPAAEYHDFLHRRGPRFGRDGQPEAEGEFSTATGSNFNGNGHFRLDTRIICAELPDGQTGHGGAPTDPVIGSSVDVWGHYNPYLRTTVNRARVLDLDPASRWTAALMVGRFGLGRRGRSHDDGYLFTGAVSGLHPPRWVDFHHIRDVGDHVLAPQLRYCAVHQFVVERGSLDWLPEADRSPAVSALHAALQAGADGILVQLALDAMASPQVPDAPSQWRVRGTVAPWNAQELRTYPAGRLLVPLRGAPLHHLTVEVSRGRAVFNMVSAVAYASRAPQPGPGPLHRLGPPLDAGELELRTAGHDRLVARVPPNAYPADATCGIVTVPAEPGWQEAEEHALYLTGVGASGSRETLLTERETNIQTDEALLVLHHRDPTHGRDHAVEVPLRAYVRGRPASAGKVYVRQYFNPRALPGDSTAGAPAARCGDAVMLGMRGETWAPECVVETDEQGHGLLTLRGERAGTCRVLLCPDPADVPPADPRAPGSAWKVYDDEDALGYWAGAASLAVRVLPDDWYLDDVPRGEVDFELVHREVFAYYEHISSFMRSEVFSLADRCKVETYAELVWQMCDPANKSKTYYMPPTRDLSDPKARLLLAYLRNIQTRVRPPVTAPGPPAERPAITTRGELWTALKQAAALELSVALQYLYAAFSVPTHGAGLTYVRRGQWTAAQLELACGGGGATLHDGMRGSLLTVAREEMIHFLLVNNIIMAMGEPFHVPVIDFATLNEKLPVPLDFALEPLSVGSVQRYVALEQPAALTPEIRRGPRTTPQERAAGFTWGSVSELYAGVREGLQRVPDLFLVEKGRGGGEHHLFLRESVNRNHPDYQLEVDDLSSALFAVDLITEQGEGGPATAGGPAADASSEMSHFETFLRIGELLATGRAPGPYGRHVPWSPAYPVLRNPTLKAGDGARTVITDPEARTVAALFNRSYHLMLQLMAQHFGESPDASLRRSKLMNASIDVMTGMMRPLAELLVTMDSGRRGRTAGPTFELDVVPAACPRPDVARRSLALRFAHLATAARRCAPVPRQVSDLMAFYADFFQRAEGT	MNVSTALRQAVVRTPWYAKRKSYKVLFWREITPLAIPIFLENTCVLLMGVLSTFLVSWLGKEAMAGVGLADSFNMVIMAFFAAIDLGTTVVVAFSLGKRDRRRARAAARQSLVIMTLFAVVLAVVIHYFGSEIINIVAGEATPEVKGLALTYLELTVLSYPAAAIALIGSGALRGAGNTKIPLMINGGMNILNIIISSILIYGAFSWQGLGFAGAGLGLTISRYIGAVAIIWVLMIGFNPALRIPLKSYLKPLNFGIIWEVMGIGIPASIESVLFNGSKLLTQMFVAGMGTNVIAGNFIAFSVAALINLPGNALGSASTIITGKRLGTGQIGQAERQLRHVFWMSTIVLTAIAWGTAPFAGLFASFYTQEQDVKEVVKVLLWLNAAFMPIWAAAWVLPSGFKGARDVRFAMWVSMLGMWGCRVVAGYTLGIVLGMGVVGVWLGMFLDWAVRGALFYWRLISGRWLWRYPRVKRE	230.17	gnl|BL_ORD_ID|1650|hsp_num:0	1752			711	864	ciprofloxacin
BGC0001224.1|Reductasporine_5 # 7261 # 8427 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.698	BGC0001224.1|Reductasporine_5 	7261	8427	+	Loose	900	28.1054	ANT(3'')-II-AAC(6')-IId bifunctional protein	36.51	3002598	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	aminoglycoside bifunctional resistance protein	ATGGACCCGTACTCCTTTTACCGCCGTTACCGTGAGAGCGACCCGGTACACCTCGGCGCGAACGGCTCCTTTTACGTCTTCCGGCACAGCGACGTGGTGCGCGTCCTGGCCGACCGACGCTACGTTCGCGGACCGCACCCGGTCCGGATCCCTCCGGACTGCCCGCATCTGAGGCGTACCACGGCCAACTGGATGGTCTTCATGGACCCACCGCGCCACACCCGGGTGCGCACGCTGGTGGCCAGAAGTTTCACCCCGCGCATCGTGGAGGGGCTGCGTCCGCGCATCCGGCGGCTGGCGGCGTCGCTCGTCACCGCGCTCGGCGAGGAGGATGAGGCCGACCTGGTCGACGGTCTGGCCGCGCCCTTCCCGCTGCTGGTCATCAGCGAACTGCTGGGCGTACGGCACGAGGAGCGCACGTGGTTCCGCGCACGCGCGCTGGATCTCCAGCAGGCTACCGGCTCACGCGTCGCCCGCAGGGCCGACGGCTTCGCTGTGGCGGAGGTGGCGGCCCGTGAGCTTGACGCCTACTTCCGCGCGGAGCTGGCACGGCGCAGGGCACGGCCGGCCCGTACAGATCTCATCGGGGCCATGCTGGACCACAGCGAGGCGACGTCGGCCGACGACGACACACTGGTCGGCACCTGCATCCACCTCCTGACCGCGGGGCACGAGACCACCACACATCTGCTGAGCAAGGGCCTGCTTGCCCTGTTTGCCCATCCCGGCCAGCTCGCGGCGCTGCGCGCGCGGCCGGCACTGATGGTGAACGCGTTGGAGGAGCTGGTCCGTTACGACGCACCCGTGCAGATGATCACCCGGTGGGCCGCAGAGGACGCACGGGTGGGAGAACGCACGATCCCCGGCGGCAGCCGCGTCGTCCTCGTCCTGGGCTCGGCCAACCGCGACCCCGAGCAGTTCCCGGACCCCGACCGCCTGGACATCACCCGACACGCGCTGCGTCACAGCGGCTTCGGCTTCGGCAGCCATTACTGCGTGGGCGCTCCACTGGCCCGTGCGGAGGCAGAGATCGCCCTCACGGAACTCCTGCACCGGCTGCCCCGCCTTGCCTTGTCCGACGAGCCGGTCCACTACGGGGATGACCTGGTGTTCCACGGACCGGATCGGATGATGGTGCGGACGGGATGTGGGCTTGATCCGCTGTGA	MDPYSFYRRYRESDPVHLGANGSFYVFRHSDVVRVLADRRYVRGPHPVRIPPDCPHLRRTTANWMVFMDPPRHTRVRTLVARSFTPRIVEGLRPRIRRLAASLVTALGEEDEADLVDGLAAPFPLLVISELLGVRHEERTWFRARALDLQQATGSRVARRADGFAVAEVAARELDAYFRAELARRRARPARTDLIGAMLDHSEATSADDDTLVGTCIHLLTAGHETTTHLLSKGLLALFAHPGQLAALRARPALMVNALEELVRYDAPVQMITRWAAEDARVGERTIPGGSRVVLVLGSANRDPEQFPDPDRLDITRHALRHSGFGFGSHYCVGAPLARAEAEIALTELLHRLPRLALSDEPVHYGDDLVFHGPDRMMVRTGCGLDPL	MSNAVPAEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAQLDETVRQALVVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPARRELQFGEWQRKDILAGIFEPATTDVDLAILLTKVRQHSLALAGSAAEDFFNPVPEGDLFKALSDTLKLWNSQPDWEGDERNVVLTLSRIWYSAATGKIAPKDIVANWAIERLPDQHKPVLLEARQAYLGRGEDCLASRADQLAAFVHFVKHEATKLLGAMPVMSKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	83.80	gnl|BL_ORD_ID|4929|hsp_num:0	339			96	273	dibekacin; sisomicin; netilmicin; spectinomycin; streptomycin; tobramycin; gentamicin A; 2'-N-ethylnetilmicin; 5-episisomicin; gentamicin
BGC0001224.1|Reductasporine_6 # 8635 # 9834 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.689	BGC0001224.1|Reductasporine_6 	8635	9834	+	Loose	300	26.1794	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide	36.51	3003394	protein variant model	V139L, I133T, W119R	n/a	pyrazine antibiotic	antibiotic target alteration	Pyrazinamide resistant pncA	ATGGAGAACGCGGCAACGGTATGCATCGGTGTAGTGGCGCCATTGACGGGACGGCTCGCCCCCCTGGGGGAGCCCCTGTCATTCGTACTGCGGAAACTGGCACCCCACCTGACGGGCTTCCGTAACGGCGACCGCCCTTTCCGAGTGCGGGTAGCCGTGCGTGACAGCCGCTCGGAGGCACAGGCTGCCCGGCAGGCCGTGCGGGAACTGGCACAGGACGAGCAGGCGGCCATGGTGCTCACCATGGCCGGCACCCAGGTACTGCCCGCCGTCACCGACACCTGTGAACAACTGGGTGTGCCGTGTGTGTCGACGACCTTTCCCTGGCAGGCCTACGGCTATGCGCGCTGCGGGGACGCCTTTGGCTCGTTCCGCTGGACGTACCATTTCGCGTGGGGCCTGGACGACATCGCGAACGCCTTCGCCGACGTGTGGGAACAACTGCCCGCACAGCCCACCGTCGGAAGCCTCTGGAACGACGGCCTGCAAGGACGGCTGCTTCGCGATGAACACATCGGCTTCGTGGCGGCCGCCTCCCGGCGCGGGCACCATGTGATCGACCCGGGCGCCTACGCGGAACCGGCCACCGACTTCACCCCGCACCTGAACCGCCTGCGCAAAGACGGCGTCGATGTCGTCACCAGCGCCGCCACCGCCACCGACCTGGCACTCTTCCACCGCCAAGCCCGCGCATCAGGCCTGCGTCCCCGCCTGATCACCTGCTCACGCTGGCTGACCTACCCCCACACGGAAGTCGCACAGTCGCGGCAGGTACACGACGAACTGGCCGACACCCGGGTGGCCACGCTCGTGTACTGGACACCCGCACACCCCCACCGCTCCAGCCTCGACGGCACCAGCTGCGCACAACTCGCGGACGCCTACGAACAGACCACCGGCAAGCCGTGGCTGCAGCCGCTCGGCCTGGCCCACGCCCTGGTGGAGGTCGCCCACCACACGCTGACAACCGCATCCGACCCCACCGACCGGGCCGCCGTCGCACGCACCCTCCAGCAGACCCGCGTCGAAACCATCGTCGGAACCCTCGACTTCACCGCCGGCCCCACACCGAACGTCGCACTGATCCCCCTGGCCGGAGGCCAATGGCACCCCACCGCCCACGGGCCACGCCTCGCCGTGGTCGCCAACTCCCGCACTCCGCATGTTCCGGTCACCGCTGATCTGGTACCGGCGTATTGA	MENAATVCIGVVAPLTGRLAPLGEPLSFVLRKLAPHLTGFRNGDRPFRVRVAVRDSRSEAQAARQAVRELAQDEQAAMVLTMAGTQVLPAVTDTCEQLGVPCVSTTFPWQAYGYARCGDAFGSFRWTYHFAWGLDDIANAFADVWEQLPAQPTVGSLWNDGLQGRLLRDEHIGFVAAASRRGHHVIDPGAYAEPATDFTPHLNRLRKDGVDVVTSAATATDLALFHRQARASGLRPRLITCSRWLTYPHTEVAQSRQVHDELADTRVATLVYWTPAHPHRSSLDGTSCAQLADAYEQTTGKPWLQPLGLAHALVEVAHHTLTTASDPTDRAAVARTLQQTRVETIVGTLDFTAGPTPNVALIPLAGGQWHPTAHGPRLAVVANSRTPHVPVTADLVPAY	MRALIIVDVQNDFCEGGSLAVTGGAALARAISDYLAEAADYHHVVATKDFHIDPGDHFSGTPDYSSSWPPHCVSGTPGADFHPSLDTSAIEAVFYKGAYTGAYSGFEGVDENGTPLLNWLRQRGVDEVDVVGIATDHCVRQTAEDAVRNGLATRVLVDLTAGVSADTTVAALEEMRTASVELVCSS	214.52	gnl|BL_ORD_ID|1945|hsp_num:0	851			276	459	pyrazinamide
